Back to the main directory
EarningsReview / Equity
- Covivio (COV FP) by HSBC
- Aster DM Healthcare (ASTERDM IN) by HSBC
- Gentera (GENTERA* MM) by HSBC
- Dixon Technologies (DIXON IN) by HSBC
- Ørsted deal in focus by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- US prescription tracker - Cosentyx & Bimzelx growing strongly by BNP Paribas Exane
- Itaú BBA on Coca-Cola FEMSA: Still-Healthy Results for 3Q24 by Itau
- Q324 results and 15 questions for management by BNP Paribas Exane
- Itaú BBA on Televisa: 3Q24 Conference Call Highlights by Itau
- Itaú BBA on Vale: 3Q24 Conference Call – Rising Visibility by Itau
- Shriram Finance Ltd (SHFL IN) by HSBC
- One last cut by BNP Paribas Exane
- CMD Feedback: Pointing to Growth by BNP Paribas Exane
- Epiroc (Hold, TP: SEK215.00) - Margins still not meeting forecast by DnB Markets
- Alfa Laval (Buy, TP: SEK580.00) - Strong mix in mixed report by DnB Markets
- Novonesis (Buy, TP: DKK500.00) - Adding company consensus by DnB Markets
- OKEA (Buy, TP: NOK29.00) - Set to end the year on a high by DnB Markets
- Evolution (Buy, TP: SEK1570.00) - Live casino resilience by DnB Markets
- Swedish Orphan Biovitrum (Hold, TP: SEK355.00) - Strong quarter, raised guidance by DnB Markets
- Coor Service Management (Buy, TP: SEK54.00) - Weak across the board by DnB Markets
- Alligo (Buy, TP: SEK175.00) - Tough (and “frustrating”) Q3 by DnB Markets
- Medistim (Hold, TP: NOK172.00) - Q3 report by DnB Markets
- Trelleborg (Hold, TP: SEK400.00) - Lacklustre demand environment by DnB Markets
- Konecranes (Buy, TP: EUR75.00) - Solid Q3 despite Service miss by DnB Markets
- Updating forecasts post Q3 results by BNP Paribas Exane
- UPS Inc (UPS US) by HSBC
- Inchcape (INCH LN) by HSBC
- Tele2 (TEL2B SS) by HSBC
- Nordnet - Uncontroversial resilience by Danske Bank Equity Research
- Revised battery contract terms should improve near-term liquidity outlook by BNP Paribas Exane
- Resilient growth despite areas of softness by BNP Paribas Exane
- Domestic revenue growth remains strong by BNP Paribas Exane
- Demand holds the key; limited downside potential by BNP Paribas Exane
- R R Kabel (RRKABEL IN) by HSBC
- Itaú BBA on Soriana: 3Q24 Results Beat Estimates; We Still Have Questions by Itau
- Bank of Baroda (BOB IN) by HSBC
- Good Quarter, Lofty Expectations: Remains Top HPC Pick Post Strong 3Q Results by BNP Paribas Exane
- Komplett (Hold, TP: NOK8.50) - Weak Q3 by DnB Markets
- Tryg (Buy, TP: DKK185.00) - Building on a solid foundation by DnB Markets
- Demant (Buy, TP: DKK360.00) - Company consensus added by DnB Markets
- Fortnox (Buy, TP: SEK83.00) - Q3 reinforced our scalability thesis by DnB Markets
- Telia Company (Buy, TP: SEK38.00) - Performing despite weaker top line by DnB Markets
- AAK (Buy, TP: SEK360.00) - Strong prices lead to good profits by DnB Markets
- Holmen (Hold, TP: SEK460.00) - Robust earnings resilience by DnB Markets
- Corem (Hold, TP: SEK8.20) - PFPM far below expectations by DnB Markets
- TietoEVRY (Sell, TP: EUR17.00) - Cost beat, but pressure on revenues by DnB Markets
- Norwegian Air Shuttle (Buy, TP: NOK14.00) - Weak Q3, bookings satisfactory by DnB Markets
- TGS (Buy, TP: NOK125.00) - Contracts likely around the corner by DnB Markets
- Komplett (Hold, TP: NOK8.00) - The game of balance by DnB Markets